The Study: In a 12-week, double-blind, placebo-controlled study, KetoneRX"s lipolytic activator compound was shown to cause targeted weight loss specifically in the form of reduced fat mass.* Healthy, overweight volunteers received either the functional KetoneRXTM compound or an indistinguishable placebo twice daily. The subjects were weighed and analyzed for total body fat at baseline and after 4 and 12 weeks of treatment. The Results: The active lipolytic activator compound in KetoneRX led to significant weight loss.* But the truly unique result was the significant and continual drop in total body fat.* After just 4 weeks, the subjects had already dropped an average of 5.5% body fat.* But even more astounding was the fact that the KetoneRX active compound continued to release fat throughout the study period, resulting in an average drop of 15.6% after 12 weeks.* That"s a consistent drop of about 5% body fat a month, every month, for the duration of the trial.**These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.